-
HPA065685-100UL
Anti-WDR83OS antibody produced in rabbit
Price: $928.29List Price: $1,031.43Immunogen WD repeat domain 83 opposite strand Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive characterization -
HPA041916-100UL
Anti-WDR88 antibody produced in rabbit (C15-1456-959)
Price: $928.29List Price: $1,031.43Immunogen WD repeat domain 88 recombinant protein epitope signature tag (PrEST) Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by -
HPA050336-100UL
Anti-WDR88 antibody produced in rabbit (C15-1460-262)
Price: $977.14List Price: $1,085.71Immunogen WD repeat domain 88 Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive characterization in the -
HPA000813-100UL
Anti-WDR89 antibody produced in rabbit
Price: $879.43List Price: $977.14Immunogen WD repeat protein 89 recombinant protein epitope signature tag (PrEST) Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by -
HPA024260-100UL
Anti-WDR91 antibody produced in rabbit
Price: $879.43List Price: $977.14Immunogen WD repeat-containing protein 91 recombinant protein epitope signature tag (PrEST) Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are -
HPA035335-100UL
Anti-WDR92 antibody produced in rabbit (C15-1453-809)
Price: $928.29List Price: $1,031.43Immunogen WD repeat domain 92 recombinant protein epitope signature tag (PrEST) Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by -
HPA035336-100UL
Anti-WDR92 antibody produced in rabbit (C15-1453-810)
Price: $928.29List Price: $1,031.43Immunogen WD repeat domain 92 recombinant protein epitope signature tag (PrEST) Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by -
HPA046196-100UL
Anti-WDR93 antibody produced in rabbit (C15-1458-771)
Price: $928.29List Price: $1,031.43Immunogen WD repeat domain 93 Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive characterization in the -
HPA048112-100UL
Anti-WDR93 antibody produced in rabbit (C15-1459-447)
Price: $928.29List Price: $1,031.43Immunogen WD repeat domain 93 Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive characterization in the -
HPA059409-100UL
Anti-WDR97 antibody produced in rabbit
Price: $928.29List Price: $1,031.43Immunogen WD repeat domain 97 Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive characterization in the -
HPA068845-100UL
Anti-WEE1 antibody produced in rabbit
Price: $928.29List Price: $1,031.43Immunogen WEE1 G2 checkpoint kinase Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive characterization in the -
HPA027418-100UL
Anti-WEE2 antibody produced in rabbit (C15-1451-481)
Price: $879.43List Price: $977.14Immunogen WEE1 homolog 2 (S. pombe) recombinant protein epitope signature tag (PrEST) Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are